<DOC>
	<DOCNO>NCT01820806</DOCNO>
	<brief_summary>This study 6 healthy male subject , receive single oral dose 100 mg [ 14C ] -radiolabeled GLPG0634 . The study aim establish elimination pathway GLPG0634 relative significance ass metabolite profile GLPG0634 plasma excreta . Furthermore , pharmacokinetics ( PK ) main metabolite plasma relative GLPG0634 evaluate . This study also provide safety tolerability information GLPG0634 .</brief_summary>
	<brief_title>Investigation Pharmacokinetics Metabolism GLPG0634 Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>male , 40 65 year age , inclusive within BMI range 18 30 kg/m2 , inclusive Any condition might interfere procedure test study Drug alcohol abuse Smoking</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>